Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting
Dr. Laila El-Khattabi (Sorbonne University Hospitals and the Brain Institute, Paris, France) will share results from the CHROMAPS project, a multi-institutional European collaboration utilizing OGM to ...
Bionano Genomics announces publication reporting first use of OGM to detect CAG
Bionano Genomics (BNGO) announced a study published in the American Journal of Hematology demonstrating the potential utility of optical genome ...
How can you increase OGM budget by 200%? – Abdul-Kabiru on gov’t spending
Member of Parliament for Walewale, Dr. Mahama Tiah Abdul-Kabiru has raised concerns over what he describes as extravagant spending under President Mahama’s administration, questioning the ...
Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML
Bionano will host a webinar featuring the study’s lead author, Dr. Guilin Tang, who will discuss the study and its findings in detail, including a summary of the potential implications for wide-spread ...
Yahoo Finance1d
Bionano Genomics, Inc. (BNGO)
Dr. Adam Smith (University of Toronto, Canada; currently at Labcorp, USA) will provide an overview of OGM’s evolution into an essential tool for hematological malignancy research and its role in ...
Ghana News Agency (GNA) on MSN7d
Minority alleges government has borrowed GH¢73b in two months
Minority in Parliament on Thursday alleged that the Mahama-led Government has borrowed GH¢73 billion in two months since ...
Morningstar8d
Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML
Based on the OGM findings, clinical researchers found higher than anticipated rates of CAG in AML (16% of cases overall and approximately two-thirds of cases with high-risk cytogenetic profiles ...
manilatimes8d
Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML
Based on the OGM findings, clinical researchers found higher than anticipated rates of CAG in AML (16% of cases overall and approximately two-thirds of cases with high-risk cytogenetic profiles), ...
Bionano Genomics: Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML
Bionano will host a webinar featuring the study's lead author, Dr. Guilin Tang, who will discuss the study and its findings in detail, including a summary of the potential implications ...